← United States · All US Insider Profiles

US INSIDER PROFILE · NON-SCORING RESEARCH

Vitoc Vlad

Chief Executive Officer | Officer

Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001913257

Purchase history

Companies traded
1
Purchases · 12M
7
Purchases · 24M
7
Average purchase
$56.2K
Median purchase
$80.1K
Gross purchase value
$393.2K

Companies: MAIA Biotechnology, Inc.

7 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.

Qualifying purchase disclosures

PublishedCompanyTickerRoleReported valueSEC source
2026-09-15MAIA Biotechnology, Inc.MAIAChief Executive Officer | Officer$100.0KOpen filing
2026-06-02MAIA Biotechnology, Inc.MAIAChief Executive Officer | Officer$101.1KOpen filing
2025-12-04MAIA Biotechnology, Inc.MAIAChief Executive Officer | Officer$80.1KOpen filing
2025-12-04MAIA Biotechnology, Inc.MAIAChief Executive Officer | Officer$10.2KOpen filing
2025-12-01MAIA Biotechnology, Inc.MAIAChief Executive Officer | Officer$80.1KOpen filing
2025-11-28MAIA Biotechnology, Inc.MAIAChief Executive Officer | Officer$10.2KOpen filing
2025-11-25MAIA Biotechnology, Inc.MAIAChief Executive Officer | Officer$11.6KOpen filing

Post-purchase outcomes

Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.

PeriodCompleted eventsPrice coverageHit rateMedian excess returnAverage excess returnWorst excess return
5D7Developing100.0% (7/7)71.4% (5/7)+2.0%+12.7%-0.7%
20D7Developing100.0% (7/7)85.7% (6/7)+21.9%+17.5%-16.4%
60D6Developing100.0% (6/6)100.0% (6/6)+56.6%+63.0%+0.4%
120D5Developing100.0% (5/5)60.0% (3/5)+4.7%+6.1%-1.3%

Research patterns

First purchase in 12M
1/7
Large purchase ≥ $100k
2/7
Cluster buying · 15D
6/7
Buying the dip
7/7

Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.

Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.